Company CVAbout Medico Remedies Ltd 
Medico Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Medico Remedies Limited was incorporated as a Private Limited Company with the name "Medico Remedies Private Limited" on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017.
Company Coordinates
Company Details
1105/1106 11-Flr Hubtown Solar, N S Phadke Marg Andheri East Mumbai Maharashtra : 400069
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 16.60 Cr
Number of Shares
8.3 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
16-Mar-2023
8.3
16.60
66387200
2
Stock Split
16-Nov-2021
1.66
16.60
12447600
10
Bonus Issue
08-Feb-2018
41.49
4.15
949200
10
Public Issues
06-Feb-2018
41.49
4.15
949200
10
Public Issue
01-Sep-2016
32
3.20
1600000
10
Bonus
01-Sep-2016
32
3.20
1600000
10
Bonus Issue
30-Dec-2014
16
1.60
340000
10
Right Issues
30-Dec-2014
16
1.60
340000
10
Right Issues
30-Mar-2014
12.6
1.26
231000
10
Allotment of Equity To Others
30-Mar-2014
12.6
1.26
231000
10
further allotment
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 5 FIIs (0.39%)
Promoter with highest holding
Haresh Kapurlal Mehta (20.76%)
Highest Public shareholder
Ravi Goyal HUF (6.6%)
Individual Investors Holdings
18.08%
Board of Directors
Management
Designation
Remuneration
Haresh Mehta
Chairman & Wholetime Director
58.86 lacs
Harshit Mehta
Managing Director
49.05 lacs
Rita Mehta
Director
0
Rishit Mehta
Whole-time Director
49.05 lacs
Deepak Vekaria
Independent Director
6.0 k
Ramesh Rughani
Independent Director
6.0 k
Bharat Rathod
Independent Director
6.0 k
Dinesh Modi
Company Sec. & Compli. Officer
0
Deepesh Shah
Independent Director
6.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
80.34167
0%
Raw Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Income - Transfer of DEPB License
1.34
1.37%
Other Operating Income - Transfer of DEPB License
Other Operating Income - Transfer of DEPB License
Stock DNARevenue and Profits:
Net Sales:
39 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
Pharmaceuticals & Drugs
INR 479 Cr (Micro Cap)
54.00
33
0.00%
0.18
15.94%
8.65
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
